REDHAWK APPOINTS PHILIP C. SPIZALE CHIEF EXECUTIVE
OFFICER
25-year Healthcare Veteran Takes the
Reins as Company Sales
Projected to Expand during the Current Fiscal
Year
G. Darcy Klug to Remain as Chairman and CFO
LAFAYETTE, LA -- May
20, 2020 -- InvestorsHub NewsWire --
RedHawk Holdings Corp. (OTC:
SNDD) ("RedHawk" or the "Company"),
a diversified
holding company primarily engaged in the sales and distribution of
medical devices, announced today that the
Board of Directors (the "Board") has appointed Philip C. Spizale as
Chief Executive Officer, effective June 8, 2020. Mr. Spizale
replaces G. Darcy Klug who has served as the Company's
Interim
Chief Executive Officer since November 12, 2018. Mr. Klug will
remain as the Company's Chairman of the Board and Chief Financial
Officer.
Mr. Spizale joined
RedHawk as a healthcare advisor to the Board in November
2017. He was
appointed as a member of the Board effective
on
July 1, 2019
and
serves as Chairman
of the Company's Compensation Committee. Mr. Spizale has more than
25
years of sales and
management experience in the healthcare industry. Since he joined RedHawk's
Board, he has assisted in developing the Company's
marketing
strategies for sales and distribution of its medical devices
as well as
identifying critical future business development opportunities that
are currently under consideration.
Commenting on the
appointment, G. Darcy Klug, RedHawk's Chairman of the Board
and Chief Financial Officer, said, "The appointment of
Philip
as our Chief
Executive Officer represents another exciting and major milestone
in RedHawk's history. In his new role, Philip will be responsible
for overseeing the planning, development, and
execution of RedHawk's marketing and advertising initiatives
including working directly with our customers, distributors, and
independent sales representatives. We believe his appointment is
the right choice to enable Redhawk to continue on its current
growth trajectory as our product line
continues to develop and expand and is projected to
achieve
quarterly
revenue records during the current
fiscal
year
compared to the
same periods in prior fiscal years."
"In addition to
his superior
management talents, Philip brings a wealth of extremely meaningful
healthcare industry knowledge and experience to RedHawk. Since he
began working with us in 2017, he has been instrumental in
developing our marketing strategies for the launch of
both
the SANDD mini™ and the
re-designed SANDD Pro™, as well as the
development of our expanded portfolio of medical personal
protection equipment, including a line of UV sanitizers. As CEO,
Philip will also work closely with me to identify and complete
specific
strategic and organic business development opportunities including
several currently under consideration," concluded Mr.
Klug.
Mr. Spizale added,
"I'm looking forward to joining the Redhawk executive team full
time. This is an exciting and important time at RedHawk as we move
to capitalize on several product line expansion opportunities and
re-energize our brand positioning. As I transition, Darcy will
shift his attention towards investor relations and strategic
business opportunities and importantly focus more directly on the
Chief Financial Officer role in order to ensure that the necessary
financial support is in place for RedHawk's planned future
growth."
In the four years
prior to joining
RedHawk, Mr. Spizale was the Chief Sales Officer
of REVA, Inc., the largest fixed wing air medical
transport service provider in the Americas. Between 2003 and 2016, Mr.
Spizale held various senior sales and managerial positions with
Concentra Inc., a national health care provider of a wide range of
medical services to employers and patients,
including urgent care, occupational medicine, physical therapy,
primary care, and wellness programs. Mr. Spizale earned a Master of Business
Administration degree from Webster University in St.
Louis,
MO and a
Bachelor of Arts degree in Communications from
Loyola University in New Orleans, LA.
# # #
About RedHawk Holdings Corp.
RedHawk Holdings Corp., formerly Independence Energy Corp., is
a diversified holding company primarily engaged in the
sale and distribution of medical devices
including the Sharps and Needle Destruction Device
(SANDD™), certain Personal Protection Equipment, UV Sanitizers,
WoundClot Surgical - Advanced Bleeding Control, and the Carotid
Artery Digital Non-Contact Thermometer. Other
subsidiaries include the
Company's United Kingdom-based
affiliate, which
manufactures and markets
branded generic pharmaceuticals and RedHawk
Energy, which holds the exclusive U.S.
manufacturing and distribution rights for the Centri Controlled
Entry System, a unique, closed cabinet, nominal
dose transmission full-body x-ray scanner.
Redhawk Holdings is also engaged in
commercial real estate investment and
leasing, and specialized financial services.
For more information, please visit: http://www.redhawkholdingscorp.com
Cautionary Statement Regarding Forward-Looking
Statements
This release may contain forward-looking statements.
Forward-looking statements are all statements other than statements
of historical fact. Statements contained in this
release that are not historical facts may be deemed to be
forward-looking statements. The words "anticipate," "may," "can,"
"plans," "believes," "estimates," "expects," "projects," "targets,"
"intends," "likely," "will," "should," "to be,"
"potential" and any similar expressions are intended to identify
those assertions as forward-looking statements.
Investors are cautioned that forward-looking statements are
inherently uncertain. Actual performance and results may differ
materially from that projected or suggested
herein due to certain risks and uncertainties, including
risks and uncertainties related to economic conditions and changes
in market conditions. In evaluating
forward-looking statements, you should consider the various
factors which may cause actual results to differ
materially from any forward-looking statements including those
listed in the "Risk Factors" section of our latest 10-K
report. Further, the Company may make changes to its
business plans that could or will affect its
results. Investors are cautioned that the Company will undertake no
obligation to update any forward-looking statements.
Company
Contacts:
G. Darcy
Klug, Chairman and CFO
(337)
269-5933
darcy.klug@redhawkholdingscorp.com
Philip C.
Spizale, CEO
(337)
269-5933
philip.spizale@redhawkholdingscorp.com
Investor
Relations:
Stephanie
Prince, Managing Director
PCG
Advisory
(646)
762-4518
sprince@pcgadvisory.com
Media
Contact:
Valerie Allen
Valerie Allen
Public Relations
(310)
382-7800
valerie@valerieallenpr.com
RedHawk (CE) (USOTC:SNDD)
Historical Stock Chart
From Aug 2024 to Sep 2024
RedHawk (CE) (USOTC:SNDD)
Historical Stock Chart
From Sep 2023 to Sep 2024